Dual-targeting antagonists (PrimeGene)
双靶向拮抗剂（普祺医药）
Report date: 2022/07/27 09:36:15
NME
Base Information
Drug NameDual-targeting antagonists (PrimeGene)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesPrime Gene Therapeutics Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesPrime Gene Therapeutics Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A